Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

Summary

This randomized, active-controlled, parallel-arm, single-blind trial is to compare the effects of Dopamine agonists (DA) therapy targeting different established treatment strategies on glucose metabolism assessed by an oral glucose tolerance test.

Timeline

Start

2025-09-16

Primary completion

2029-12-31

Completion

2029-12-31

Drugs

Indications